RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/18308734http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/18308734http://www.w3.org/2000/01/rdf-schema#comment"ATF3 stimulated promoter activity of EphA1 by 3.4-fold in ATF3-dependent angiogenesis in vitro. Although tyrosine kinase activation of EphA1 was dispensable, binding of EphA1 to fibronectin through its type I repeat played an essential role in the angiogenesis. Recombinant proteins containing fibronectin 10th to 12th type I repeat (I 10-12) but not I 12 could inhibit the angiogenesis in vitro by competitively targeting EphA1 with the full-length fibronectin. However, I 12 acquired a higher affinity toward EphA2 with K(d) 18 nm and inhibited vascular endothelial growth factor-dependent angiogenic invasion in a Matrigel plug assay."xsd:string
http://purl.uniprot.org/citations/18308734http://purl.org/dc/terms/identifier"doi:10.1074/jbc.m702164200"xsd:string
http://purl.uniprot.org/citations/18308734http://purl.uniprot.org/core/author"Masuda J."xsd:string
http://purl.uniprot.org/citations/18308734http://purl.uniprot.org/core/author"Maru Y."xsd:string
http://purl.uniprot.org/citations/18308734http://purl.uniprot.org/core/author"Usui R."xsd:string
http://purl.uniprot.org/citations/18308734http://purl.uniprot.org/core/date"2008"xsd:gYear
http://purl.uniprot.org/citations/18308734http://purl.uniprot.org/core/name"J Biol Chem"xsd:string
http://purl.uniprot.org/citations/18308734http://purl.uniprot.org/core/pages"13148-13155"xsd:string
http://purl.uniprot.org/citations/18308734http://purl.uniprot.org/core/title"Fibronectin type I repeat is a nonactivating ligand for EphA1 and inhibits ATF3-dependent angiogenesis."xsd:string
http://purl.uniprot.org/citations/18308734http://purl.uniprot.org/core/volume"283"xsd:string
http://purl.uniprot.org/citations/18308734http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/18308734
http://purl.uniprot.org/citations/18308734http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/18308734
http://purl.uniprot.org/uniprot/P29596#attribution-4DBA39DF3382971D14CD02476D6A9280http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/P18847#attribution-1771EB1BD221876D9801D3EF7CFEFE2Ahttp://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/P21709#attribution-4DBA39DF3382971D14CD02476D6A9280http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/D3ZDH4#attribution-28D2E106D1923F92614E30F473FB95D3http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/#_A8K2T6-mappedCitation-18308734http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/#_D3ZDH4-mappedCitation-18308734http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/#_A0A8I6AAL3-mappedCitation-18308734http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/#_A0A8I6AH50-mappedCitation-18308734http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/#_P21709-mappedCitation-18308734http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/#_Q62281-mappedCitation-18308734http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/#_Q7TPG4-mappedCitation-18308734http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18308734
http://purl.uniprot.org/uniprot/#_L8EAE3-mappedCitation-18308734http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18308734